1-2 of 2
Jennifer Lin, MA, MS
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Single-Agent Ibrutinib Versus Chlorambucil-Obinutuzumab As First-Line Treatment in Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (CLL/SLL): Results of a Cross-Trial Comparison

Alessandra Tedeschi, MD, Richard Greil, MD, Fatih Demirkan, MD, Tadeusz Robak, MD PhD, Carol Moreno, MD PhD, Paul Barr, MD, Bertrand Anz, MD, David Simpson, MBChB, FRACP, FRCPA, Gianluca Gaidano, MD PhD, Osnat Bairey, MD, Don Stevens, MD, Devinder Gill, MD MRCP, FRCPath, Ian W. Flinn, MD PhD, Thomas J. Kipps, MD PhD, Jan A. Burger, MD PhD, Jennifer Lin, MA, MS, Thomas Webb, MSc, Viktor Fedorov, MD, Lori Styles, MD, John G. Gribben
Journal: Blood
Blood (2018) 132 (Supplement 1): 5565.
https://doi.org/10.1182/blood-2018-99-111369
Published: 2018
Journal Articles

Updated Efficacy Including Genetic and Clinical Subgroup Analysis and Overall Safety in the Phase 3 RESONATE TM Trial of Ibrutinib Versus Ofatumumab in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Jennifer R. Brown, MD PhD, Peter Hillmen, MB, ChB, PhD, Susan O'Brien, MD, Jaqueline C. Barrientos, MD, Nishitha Reddy, MBBS, MScl, Steven Coutre, MD, Constantine Tam, MD, Stephen Mulligan, MBBS, MD FRACP, FRCPA, Ulrich Jaeger, MD, Paul M. Barr, MD, Richard R. Furman, MD, Thomas J. Kipps, MD, Florence Cymbalista, MD, Patrick Thornton, MD, Federico Caligaris-Cappio, MD, Julio Delgado, MD, Marco Montillo, MD, Sven DeVos, MD, Carol Moreno, MD, John Pagel, MD PhD, Jan A. Burger, MD PhD, Devon Chung, BS, Jennifer Lin, MA, MS, Linda Gau, MS, Betty Chang, PhD, Jesse McGreivy, MD, Danelle F. James, MD MAS, John C. Byrd, MD
Journal: Blood
Blood (2014) 124 (21): 3331.
https://doi.org/10.1182/blood.V124.21.3331.3331
Published: 2014